Speaker illustration

Doctor Hans Nienhuis

Groningen (Netherlands (The))

Discussion and closing remarks.

Event: Heart Failure 2022

Topic: Clinical

Session: New targets to enhance survival and outcomes in hATTR amyloidosis

Thumbnail

Treatment strategies targeting TTR amyloid in hATTR amyloidosis (a multi-system disease).

Event: Heart Failure 2022

Topic: Clinical

Session: New targets to enhance survival and outcomes in hATTR amyloidosis

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb